These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1355969)

  • 21. [2nd level uptake of neurotransmitters in the central nervous system and its implications in physiopathology].
    Vamvakides A
    Agressologie; 1981; 22(4):169-77. PubMed ID: 6118070
    [No Abstract]   [Full Text] [Related]  

  • 22. [Structural and functional cerebral changes in patients with schizophrenia].
    Rubin PJ; Hemmingsen RP
    Ugeskr Laeger; 1993 Jan; 155(1):16-21. PubMed ID: 8421841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Possibilities in the treatment of schizophrenia based on biochemical findings].
    Nagashi M
    Seishin Shinkeigaku Zasshi; 1985; 87(7):435-43. PubMed ID: 2867568
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients.
    DeLisi LE; Buchsbaum MS; Holcomb HH; Dowling-Zimmerman S; Pickar D; Boronow J; Morihisa JM; van Kammen DP; Carpenter W; Kessler R
    Am J Psychiatry; 1985 Jan; 142(1):78-81. PubMed ID: 3871312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The biology of schizophrenia: current status and perspectives of its knowledge].
    Díaz JL
    Rev Invest Clin; 1986; 38(1):89-110. PubMed ID: 2874601
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo PET and SPECT receptor imaging: new technology and tactics for receptor measurement.
    Wong DF; Kuhar MJ
    Adv Exp Med Biol; 1988; 236():181-93. PubMed ID: 2907237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dementing conditions studied with PET.
    Leenders KL; Aquilonius SM
    J Neural Transm Suppl; 1987; 24():31-41. PubMed ID: 2890710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The transport of tyrosine into the human brain as determined with L-[1-11C]tyrosine and PET.
    Wiesel FA; Blomqvist G; Halldin C; Sjögren I; Bjerkenstedt L; Venizelos N; Hagenfeldt L
    J Nucl Med; 1991 Nov; 32(11):2043-9. PubMed ID: 1941137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET in psychopharmacology.
    Maria Moresco R; Messa C; Lucignani G; Rizzo G G; Todde S; Carla Gilardi M; Grimaldi A; Fazio F
    Pharmacol Res; 2001 Sep; 44(3):151-9. PubMed ID: 11529683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Brain imaging in schizophrenia -- especially by Computed Tomography].
    Szulc A
    Psychiatr Pol; 1994; 28(2):145-56. PubMed ID: 8208861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutamatergic aspects of schizophrenia.
    Tamminga C
    Br J Psychiatry Suppl; 1999; (37):12-5. PubMed ID: 10211134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low frontal glucose utilization in chronic schizophrenia: a replication study.
    Wolkin A; Angrist B; Wolf A; Brodie JD; Wolkin B; Jaeger J; Cancro R; Rotrosen J
    Am J Psychiatry; 1988 Feb; 145(2):251-3. PubMed ID: 3257653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural and functional brain imaging in schizophrenia.
    Cleghorn JM; Zipursky RB; List SJ
    J Psychiatry Neurosci; 1991 Jul; 16(2):53-74. PubMed ID: 1911736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands.
    Farde L; Hall H
    Arzneimittelforschung; 1992 Feb; 42(2A):260-4. PubMed ID: 1316756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward a brain map of auditory hallucinations.
    Cleghorn JM; Franco S; Szechtman B; Kaplan RD; Szechtman H; Brown GM; Nahmias C; Garnett ES
    Am J Psychiatry; 1992 Aug; 149(8):1062-9. PubMed ID: 1353314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia.
    Volkow ND; Wolf AP; Van Gelder P; Brodie JD; Overall JE; Cancro R; Gomez-Mont F
    Am J Psychiatry; 1987 Feb; 144(2):151-8. PubMed ID: 3492931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Brain imaging and schizophrenia].
    Martinot JL; Dao-Castellana MH
    Rev Prat; 1991 Mar; 41(7):611-4. PubMed ID: 2028204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neurotransmitters and neuropeptides in schizophrenia].
    Toru M; Ichikawa H
    Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1838-54. PubMed ID: 6085408
    [No Abstract]   [Full Text] [Related]  

  • 39. Positron emission tomography for quantitative in vivo studies of neurotransmitter kinetics: a critical evaluation.
    Greitz T
    Adv Biochem Psychopharmacol; 1984; 39():69-78. PubMed ID: 6147069
    [No Abstract]   [Full Text] [Related]  

  • 40. Brain organization in schizophrenia.
    Volkow ND; Brodie JD; Wolf AP; Gomez-Mont F; Cancro R; Van Gelder P; Russell JA; Overall J
    J Cereb Blood Flow Metab; 1986 Aug; 6(4):441-6. PubMed ID: 3488322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.